https://www.selleckchem.com/products/Taurine.html
This review highlights some important preclinical research on drug conjugates in recent years. We focus on three significant areas improvement of antibody-drug conjugates, identification of new conjugate targets, and development of new types of drug conjugates, including nanotechnology. We close by highlighting the critical barriers to clinical translation and the open questions going forward. SIGNIFICANCE STATEMENT The development of anticancer drug conjugates is now focused in three broad areas improvements to existing antibody drug c
Like
Comment
Share
